News
Important Only
ReutersFri, Aug 8
Tenax Therapeutics Inc <TENX.OQ> expected to post a loss of 24 cents a share - Earnings Preview
ReutersFri, Aug 8
EXCLUSIVE-Harvard patents targeted by Trump administration
ReutersFri, Aug 8
Lument Finance Trust Inc reports results for the quarter ended June 30 - Earnings Summary
ReutersFri, Aug 8
Oramed Pharmaceuticals Inc <ORMP.OQ> expected to post a loss of 19 cents a share - Earnings Preview
ReutersFri, Aug 8
X4 Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
ReutersFri, Aug 8
Marchex Inc <MCHX.OQ> expected to post a loss of 1 cent a share - Earnings Preview
Other
Tenax Therapeutics Inc expected to post a loss of 24 cents a share - Earnings Preview
Tenax Therapeutics Inc TENX.OQ TENX.O is expected to show no change in quarterly revenue when it reports results on August 11 (estimated) for the period ending June 30 2025LSEG's mean analyst estimate for Tenax Therapeutics Inc is for a loss of 24 cents per share. The current average analyst ...Reuters
Fri, Aug 8
Other
EXCLUSIVE-Harvard patents targeted by Trump administration
Harvard allegedly breaches legal, contractual obligationsUS threatens to take ownership of patents or grant licensesHarvard not available for commentBy Jonathan Stempel Aug 8 (Reuters) - The Trump administration on Friday ordered a comprehensive review of Harvard University's federally funded...Reuters
Fri, Aug 8
Stocks
Lument Finance Trust Inc reports results for the quarter ended June 30 - Earnings Summary
Lument Finance Trust Inc LFT.N reported quarterly adjusted earnings of 5 cents per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of 9 cents. The mean expectation of two analysts for the quarter was for earnings of 8 cents per share. Wall...Reuters
Fri, Aug 8
Other
Oramed Pharmaceuticals Inc expected to post a loss of 19 cents a share - Earnings Preview
Oramed Pharmaceuticals Inc ORMP.OQ ORMP.O is expected to show no change in quarterly revenue when it reports results on August 12 (estimated) for the period ending March 31 2025LSEG's mean analyst estimate for Oramed Pharmaceuticals Inc is for a loss of 19 cents per share. The mean earnings ...Reuters
Fri, Aug 8
Stocks
X4 Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
X4 Pharmaceuticals Inc XFOR.OQ reported a quarterly adjusted loss of $3.47 per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of $-2.10. The mean expectation of five analysts for the quarter was for a loss of $4.34 per share. Wall Street ...Reuters
Fri, Aug 8
Other
Marchex Inc expected to post a loss of 1 cent a share - Earnings Preview
Marchex Inc MCHX.OQ MCHX.O is expected to show a rise in quarterly revenue when it reports results on August 12 for the period ending June 30 2025The Seattle Washington-based company is expected to report a 2.7% increase in revenue to $12.4 million from $12.07 million a year ago, according to the...Reuters
Fri, Aug 8
Other
Superior Plus Corp expected to post a loss of 13 cents a share - Earnings Preview
Superior Plus Corp SPB.TO is expected to show a rise in quarterly revenue when it reports results on August 12 for the period ending June 30 2025The Toronto Ontario-based company is expected to report a 88.6% increase in revenue to $495.5 million from $262.73 million a year ago, according to the...Reuters
Fri, Aug 8
Other
Gaia Inc expected to post a loss of 8 cents a share - Earnings Preview
Gaia Inc GAIA.OQ GAIA.O is expected to show a rise in quarterly revenue when it reports results on August 11 for the period ending June 30 2025The Louisville Colorado-based company is expected to report a 10.5% increase in revenue to $24.4 million from $22.08 million a year ago, according to the ...Reuters
Fri, Aug 8
Other
UK regulator clears Boeing takeover of Spirit AeroSystems
Britain's CMA regulator began investigation in JuneCompetition authority decides against 'phase 2' in probeDeal still requires approval from European and U.S. regulatorsSpirit AeroSystems to sell Malaysian facility for $95.3 million Aug 8 (Reuters) - Britain's competition regulato...Reuters
Fri, Aug 8
Other
Insight Molecular Diagnostics Inc expected to post a loss of 23 cents a share - Earnings Preview
Insight Molecular Diagnostics Inc IMDX.OQ IMDX.O is expected to show a rise in quarterly revenue when it reports results on August 11 for the period ending June 30 2025The Nashville Tennessee-based company is expected to report a 180.8% increase in revenue to $292 thousand from $104 thousand a ye...Reuters
Fri, Aug 8
Commodities
US Plains HRW Wheat-Basis flat steady as futures sink
CHICAGO, Aug 8 (Reuters) - Spot basis bids for hard red winter wheat were unchanged in a spot check of locations in the southern U.S. Plains on Friday as futures fell. Wheat futures were down on abundant global supplies, but received some support as low prices sparked export interest. GRA/ K.C. Sept...Reuters
Fri, Aug 8
Stocks
Greenwich Lifesciences Inc expected to post a loss of 24 cents a share - Earnings Preview
Greenwich Lifesciences Inc GLSI.OQ GLSI.O is expected to show no change in quarterly revenue when it reports results on August 12 (estimated) for the period ending June 30 2025LSEG's mean analyst estimate for Greenwich Lifesciences Inc is for a loss of 24 cents per share. The one available an...Reuters
Fri, Aug 8
Other
Solomon Islands blocks US, China, Taiwan from Pacific's top political meet
Dialogue partners will not attend Pacific Islands Forum says Solomon Islands leaderDecision made amid strategic rivalry between China, U.S., TaiwanOpposition party criticises lost opportunity to meet global donorsBy Kirsty Needham SYDNEY, Aug 7 (Reuters) - Solomon Islands Prime Minister Jeremiah ...Reuters
Fri, Aug 8
Other
Nyxoah Says Co Receives Approval From FDA For Genio® System For Treatment Of Obstructive Sleep Apnea
Aug 8 (Reuters) - Nyxoah SA NYXH.BR:EQS-NEWS: NYXOAH RECEIVES APPROVAL FROM FDA FOR GENIO® SYSTEM FOR THE TREATMENT OF OBSTRUCTIVE SLEEP APNEANYXOAH SA - LAUNCHES U.S. COMMERCIALIZATIONReuters
Fri, Aug 8
Cryptocurrencies
Trump has expanded his Fed chair search from three finalists to about ten candidates
Donald Trump has decided that three finalists for the next Federal Reserve chair aren’t enough. Senior administration officials say the search has been widened to about ten possible choices. The fresh additions include former St. Louis Fed president James Bullard and longtime economic consultant Marc Sumerlin. They join a list that already had National Economic […]Cryptopolitan
Fri, Aug 8
Other
Inhibikase Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Inhibikase Therapeutics Inc IKT.OQ IKT.O is expected to show no change in quarterly revenue when it reports results on August 12 (estimated) for the period ending June 30 2025LSEG's mean analyst estimate for Inhibikase Therapeutics Inc is for a loss of 9 cents per share. The current average a...Reuters
Fri, Aug 8
